Bicycle Therapeutics plc (BCYC)
NASDAQ: BCYC · IEX Real-Time Price · USD
23.63
+0.18 (0.75%)
May 1, 2024, 2:04 PM EDT - Market open

Bicycle Therapeutics Revenue

In the year 2023, Bicycle Therapeutics had annual revenue of $26.98M with 86.52% growth. Revenue in the quarter ending December 31, 2023 was $5.33M with 67.38% year-over-year growth.

Revenue (ttm)
$26.98M
Revenue Growth
+86.52%
P/S Ratio
37.14
Revenue / Employee
$94,986
Employees
284
Market Cap
1.01B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202326.98M12.51M86.52%
Dec 31, 202214.46M2.77M23.65%
Dec 31, 202111.70M1.31M12.58%
Dec 31, 202010.39M-3.41M-24.72%
Dec 31, 201913.80M6.67M93.40%
Dec 31, 20187.14M5.08M246.41%
Dec 31, 20172.06M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
MiMedx Group 321.48M
Innoviva 310.46M
Standard BioTools 106.34M
Cronos Group 87.24M
Arcutis Biotherapeutics 59.61M
Liquidia 17.49M
Abivax 5.13M
Perspective Therapeutics 1.43M
Revenue Rankings